Pembrolizumab Antibody, CAS [[1374853-91-4]], Unconjugated

Artikelnummer: BYT-ORB1297806
Artikelname: Pembrolizumab Antibody, CAS [[1374853-91-4]], Unconjugated
Artikelnummer: BYT-ORB1297806
Hersteller Artikelnummer: orb1297806
Alternativnummer: BYT-ORB1297806-1, BYT-ORB1297806-10, BYT-ORB1297806-100, BYT-ORB1297806-2, BYT-ORB1297806-25, BYT-ORB1297806-5, BYT-ORB1297806-50
Hersteller: Biorbyt
Kategorie: Biochemikalien
Konjugation: Unconjugated
Alternative Synonym: Pembrolizumab, Pembrolizumab(anti-PD-1), PDL1, PD-L1, PD1, PD-1, PD1/PDL1, anti-PD-1
Pembrolizumab is a humanized anti-PD-1 monoclonal antibody used in research to block the PD-1/PD-L1 interaction, thereby restoring T-cell-mediated tumor killing. It is widely applied in immuno-oncology research for both in vitro T-cell activation assays and in vivo preclinical cancer models.
Konzentration: 26.7 mg/mL
Molekulargewicht: 149 kDa
Reinheit: 99.70% (May vary between batches)
CAS Nummer: [1374853-91-4]
Target-Kategorie: PD-1/PD-L1